Long-term clinical outcome of trastuzumab and lapatinib for HER2-positive metastatic colorectal cancer

作者: Federica Tosi , Andrea Sartore-Bianchi , Sara Lonardi , Alessio Amatu , Francesco Leone

DOI: 10.1016/J.CLCC.2020.06.009

关键词: OncologyConfidence intervalInternal medicineColorectal cancerLoading doseTrastuzumabPertuzumabMagnetic resonance imagingLapatinibKRASMedicine

摘要: … With the former regimen, we recently reported briefly the … lung metastasis, analyzed before HER2-targeted treatment, and … relapse in ERBB2-positive metastatic colorectal cancer: long-…

参考文章(35)
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio Garcia-Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Eveline Boucher, Marc Peeters, Ben Tran, Heinz-Josef Lenz, Alberto Zaniboni, Howard Hochster, James M Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu, None, Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer The New England Journal of Medicine. ,vol. 372, pp. 1909- 1919 ,(2015) , 10.1056/NEJMOA1414325
Simonetta M. Leto, Francesco Sassi, Irene Catalano, Valter Torri, Giorgia Migliardi, Eugenia R. Zanella, Mark Throsby, Andrea Bertotti, Livio Trusolino, Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas Clinical Cancer Research. ,vol. 21, pp. 5519- 5531 ,(2015) , 10.1158/1078-0432.CCR-14-3066
Hans-Joachim Stemmler, Manfred Schmitt, Amina Willems, Helga Bernhard, Nadia Harbeck, Volker Heinemann, Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anti-Cancer Drugs. ,vol. 18, pp. 23- 28 ,(2007) , 10.1097/01.CAD.0000236313.50833.EE
Andrea Bertotti, Giorgia Migliardi, Francesco Galimi, Francesco Sassi, Davide Torti, Claudio Isella, Davide Corà, Federica Di Nicolantonio, Michela Buscarino, Consalvo Petti, Dario Ribero, Nadia Russolillo, Andrea Muratore, Paolo Massucco, Alberto Pisacane, Luca Molinaro, Emanuele Valtorta, Andrea Sartore-Bianchi, Mauro Risio, Lorenzo Capussotti, Marcello Gambacorta, Salvatore Siena, Enzo Medico, Anna Sapino, Silvia Marsoni, Paolo M Comoglio, Alberto Bardelli, Livio Trusolino, None, A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discovery. ,vol. 1, pp. 508- 523 ,(2011) , 10.1158/2159-8290.CD-11-0109
Patricia S. Steeg, Kevin A. Camphausen, Quentin R. Smith, Brain metastases as preventive and therapeutic targets Nature Reviews Cancer. ,vol. 11, pp. 352- 363 ,(2011) , 10.1038/NRC3053
Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark Berger, Cristina Oliva, Stephen D. Rubin, Steven Stein, David Cameron, Charles E. Geyer, John Forster, Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer The New England Journal of Medicine. ,vol. 355, pp. 2733- 2743 ,(2006) , 10.1056/NEJMOA064320
Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Ramakrishna Samala, Helen R. Thorsheim, Julie Lockman, Brunilde Gril, Emily Hua, Diane Palmieri, Joseph W. Polli, Stephen Castellino, Stephen D. Rubin, Paul R. Lockman, Patricia S. Steeg, Quentin R. Smith, Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer Pharmaceutical Research. ,vol. 29, pp. 770- 781 ,(2012) , 10.1007/S11095-011-0601-8
Bernhard C. Pestalozzi, Sue Brignoli, Trastuzumab in CSF. Journal of Clinical Oncology. ,vol. 18, pp. 2349- 2351 ,(2000) , 10.1200/JCO.2000.18.11.2349
Diane Palmieri, Julie L. Bronder, Jeanne M. Herring, Toshiyuki Yoneda, Robert J. Weil, Andreas M. Stark, Raffael Kurek, Eleazar Vega-Valle, Lionel Feigenbaum, Douglas Halverson, Alexander O. Vortmeyer, Seth M. Steinberg, Kenneth Aldape, Patricia S. Steeg, Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Research. ,vol. 67, pp. 4190- 4198 ,(2007) , 10.1158/0008-5472.CAN-06-3316
Bernhard C Pestalozzi, D Zahrieh, KN Price, SB Holmberg, J Lindtner, J Collins, D Crivellari, MF Fey, E Murray, O Pagani, E Simoncini, M Castiglione-Gertsch, RD Gelber, AS Coates, A Goldhirsch, International Breast Cancer Study Group, Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) Annals of Oncology. ,vol. 17, pp. 935- 944 ,(2006) , 10.1093/ANNONC/MDL064